From Trials to Real-world Data: National Insights on Cladribine Tablets in Multiple Sclerosis After Four Years and Beyond (P8-1.009)
To evaluate long-term treatment strategies, including retreatment, in people with multiple sclerosis (PwMS) treated with cladribine tablets in real-world practice.
Authors
- Michal Dufek (ORCID: https://orcid.org/0000-0003-3773-4510)
- Zbyšek Pavelek (ORCID: https://orcid.org/0000-0002-1772-8781)
- Zuzana Rous
- Ingrid Menkyová
- Radek Ampapa
- Markéta Grünermelová
- Pavel Potuznik
- Eva Recmanová
- Ivana Woznicová
- Pavel Štourač (ORCID: https://orcid.org/0000-0001-8933-0281)
- Marta Vachová (ORCID: https://orcid.org/0000-0002-8158-724X)
- Dominika Šťastná (ORCID: https://orcid.org/0000-0003-2418-4847)
- Marek Peterka (ORCID: https://orcid.org/0000-0002-0588-4592)
- Ivana Štětkářová (ORCID: https://orcid.org/0000-0003-2699-1124)
- Jana Libertínová (ORCID: https://orcid.org/0000-0001-9737-0507)
- Eva Havrdová (ORCID: https://orcid.org/0000-0002-9543-4359)
- Jiří Drahota (ORCID: https://orcid.org/0000-0003-3416-2094)
- Gregor Fistravec
- Dana Horáková
- Alena Martinková
- Jana Houskova
Institutions
- Charles University (CZ)
- Masaryk University (CZ)
- University Hospital Ostrava (CZ)
- Hospital Jihlava (CZ)
- University Hospital Brno (CZ)
- University Hospital Olomouc (CZ)
- Nemocnice České Budějovice (CZ)
- St. Anne's University Hospital Brno (CZ)
- University Hospital Hradec Králové (CZ)
- Regional Museum in Teplice (CZ)
- Thomayer University Hospital (CZ)
- General University Hospital in Prague (CZ)
- Palacký University Olomouc (CZ)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211352
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00